J K Pharmachem Ltd.
BSE: 500218 | Sector: Health care |
NSE: JKPHARMA | ISIN Code: INE335C01018 |
BSE 05:30 | 01 Jan | J K Pharmachem Ltd is not traded on BSE in the last 30 days |
NSE 05:30 | 01 Jan | J K Pharmachem Ltd Not listed in NSE |
About J K Pharmachem Ltd.
Jointly promoted by J K Industries and TIDCO J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.'94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G based on a microbial strain from the technical collaborators -- IGC (Cyprus) Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commence...> More
J K Pharmachem Ltd - Financial Results
Particulars (![]() |
Mar 2006 | Mar 2005 | % Chg |
Net Sales | 0.17 | - | |
Other Income | 0.13 | - | |
Total Income | 0.3 | - | |
Total Expenses | 0.14 | 1.23 | -88.62 |
Operating Profit | -0.14 | -0.93 | 84.95 |
Net Profit | -1.63 | -2.73 | 40.29 |
Equity Capital | 62.68 | 62.68 | - |
J K Pharmachem Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Guj. Inject(Ker) | 8.22 | -4.53 | 4.03 |
Hind.Bio Science | 3.83 | -3.04 | 3.93 |
Kabra Drugs | 4.83 | 5.00 | 2.12 |
J K Pharmachem Ltd - SHAREHOLDING PATTERN
|
|
J K Pharmachem Ltd - STOCK STRENGTH
YEAR Low/High | 0.00 | 0.00 | |
All TIME Low/High | 1.10 | 37.00 |
Quick Links for J K Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices